BLEORHEAT

This brand name is authorized in Nigeria.

Active ingredients

The drug BLEORHEAT contains a combination of these active pharmaceutical ingredients (APIs):

1	Methyl salicylate UNII LAV5U5022Y - METHYL SALICYLATE
	Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet.
	Read more about Methyl salicylate
2	Menthol UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
	Read more about Menthol
3	Camphora UNII N20HL7Q941 - CAMPHOR (NATURAL)
	Read more about Camphora
4	Eucalyptus oil UNII 2R04ONI662 - EUCALYPTUS OIL
	When the vapour is inhaled eucalyptus oil acts to ventilate the bronchial passages and relieve bronchitis and associated conditions. It is also a rubefacient.
	Read more about Eucalyptus oil
5	Turpentine oil UNII C5H0QJ6V7F - TURPENTINE OIL
	Read more about Turpentine oil

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1150	Gel	Bleorheat Cream GEL 0.15%w/w; 0.10%w/w; 0.20%w/w; 2%w/w; 0.30%w/w 100G	Bleorheat Cream C4-1150 Methylsalicylate BP, Menthol BP, Turpentine Oil BP, Eucalyptus Oil BP, Camphor BP Rubefacient Topical 0.15% w/w, 0.10% w/w, 0.20% w/w, 2.0% w/w, 0.30% w/w Gel Over The Counter (Otc) Teka Pharma Ltd Kesar Pharma Pvt Ltd India 2020-11-10 2025-11-09	10/11/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M02AC	Preparations with salicylic acid derivatives	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain
Discover more medicines within M02AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1150